Key result
cGAS ablation cuts post-MI mortality ~93% in mice, driven by reparative macrophage transformation.
Why the study?
Macrophage transformation across phenotypes is crucial to myocardial repair after ischemic injury, but the events governing this transformation are poorly understood.
Does genetic ablation of the cGAS-STING pathway improve post-myocardial infarction survival and attenuate adverse remodeling in preclinical models?
Does genetic ablation of the cGAS-STING pathway improve post-myocardial infarction survival and attenuate adverse remodeling in preclinical models?
Absolute Event Rate: 3% vs 42%
p-value: p=<0.001
Genetic ablation of the cGAS-STING pathway improves post-myocardial infarction survival and attenuates adverse remodeling by promoting a reparative macrophage phenotype.
Hypothesis-generating for cGAS-STING inhibition post-MI; leaves clinical translation open pending larger preclinical and human studies.
BACKGROUND: Myocardium irreversibly injured by ischemic stress must be efficiently repaired to maintain tissue integrity and contractile performance. Macrophages play critical roles in this process. These cells transform across a spectrum of phenotypes to accomplish diverse functions ranging from mediating the initial inflammatory responses that clear damaged tissue to subsequent reparative functions that help rebuild replacement tissue. Although macrophage transformation is crucial to myocardial repair, events governing this transformation are poorly understood. METHODS: Here, we set out to determine whether innate immune responses triggered by cytoplasmic DNA play a role. RESULTS: We report that ischemic myocardial injury, along with the resulting release of nucleic acids, activates the recently described cyclic GMP-AMP synthase-stimulator of interferon genes pathway. Animals lacking cyclic GMP-AMP synthase display significantly improved early survival after myocardial infarction and diminished pathological remodeling, including ventricular rupture, enhanced angiogenesis, and preserved ventricular contractile function. Furthermore, cyclic GMP-AMP synthase loss of function abolishes the induction of key inflammatory programs such as inducible nitric oxide synthase and promotes the transformation of macrophages to a reparative phenotype, which results in enhanced repair and improved hemodynamic performance. CONCLUSIONS: These results reveal, for the first time, that the cytosolic DNA receptor cyclic GMP-AMP synthase functions during cardiac ischemia as a pattern recognition receptor in the sterile immune response. Furthermore, we report that this pathway governs macrophage transformation, thereby regulating postinjury cardiac repair. Because modulators of this pathway are currently in clinical use, our findings raise the prospect of new treatment options to combat ischemic heart disease and its progression to heart failure.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2018) studied Myocardial Infarction. cGAS knockout vs. Wild-type was evaluated on 1-week post-MI mortality (p=<0.001). In a murine model of myocardial infarction, genetic ablation of cGAS reduced 1-week mortality to 3% compared to 42% in wild-type mice (p<0.001) by promoting reparative macrophage transformation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: